资讯
The chronic obstructive pulmonary disease (COPD) market across the seven major markets (7MM: US, France, Germany, Italy, ...
5 天
Verywell Health on MSNOhtuvayre: The First Novel COPD Treatment Approved in Over a DecadeOhtuvayre is the first new inhaled COPD therapy approved in over two decades. COPD is a chronic inflammatory condition that ...
When prescribing an inhaled therapy it is essential ... Better instruction on inhaler technique, and regular reminders, will have an impact on COPD and asthma admission figures, which are so ...
Oxygen therapy for COPD is a treatment used to increase the oxygen (O2) in your lungs and bloodstream. Research suggests that people with chronic obstructive pulmonary disease (COPD) who use oxygen ...
Respiratory physician Lutz Beckert considers chronic obstructive pulmonary disease management, including the prevention of COPD, the importance of smoking cessation and pulmonary rehabilitation, and ...
Approved yesterday by the FDA, Trelegy Ellipta is the first ever daily single-inhaler to combine a triple therapy for COPD, and could help patients manage their condition better - around a quarter ...
Oxygen therapy for COPD is a treatment used to increase the oxygen in your lungs and bloodstream. Research suggests that people with chronic obstructive pulmonary disease (COPD) who use oxygen may ...
CONCLUSIONS NO at a concentration of 25 ppm blended with oxygen can be safely administered by nasal cannula for 24 hours without significant adverse effects and lowers PVR in stable patients with COPD ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果